Affinity Investment Advisors, LLC Lannett CO Inc Transaction History

Affinity Investment Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$4.75 - $14.5 $140,129 - $427,764	-29,501 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$13.3 - $17.45 $54,423 - $71,405	4,092 Added 16.1%	29,501 $401,000
Q1 2018 May 08, 2018	BUY	$14.7 - $24.95 $373,512 - $633,954	25,409 New	25,409 $408,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.